The Ongoing Evolution of Endothelial Keratoplast

Article

According to the Review of OphthalmologyRefinements in tools and technique are leading to better outcomes, fewer complications and promising new versions of the surgery.

According to the Review of OphthalmologyRefinements in tools and technique are leading to better outcomes, fewer complications and promising new versions of the surgery.

Endothelial keratoplasty has evolved dramatically in recent years, and it continues to do so. Each new iteration promises less trauma for the diseased eye and graft tissue, along with better visual outcomes; yet each advance is also sufficiently complex that it requires years of refinement before achieving widespread use. Here, several experts in current and upcoming variations on endothelial keratoplasty-especially Descemet’s Stripping Endothelial Keratoplasty and its partially automated variation, DSAEK-share their latest insights, experience and thoughts about what lies ahead. Read full article

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.